journal article·2023-05-12Open access

Has the Toxicity of Therapeutic Deep Eutectic Systems Been Assessed?

Cristina B. García, Julia Concha, Laura Culleré, Laura Lomba, Estela Sangüesa, Mª Pilar Ribate

Applied Sciences· Volume 13· Issue 10

Abstract

Therapeutic Deep Eutectic Systems (THEDESs) are a mixture of components, including an active pharmaceutical ingredient, that have recently emerged because of their interesting properties for drug therapies. In general, they have been recognized to increase the solubility and permeability of some drugs, and consequently, their bioavailability. Moreover, they have also been used for novel formulations of pharmaceuticals. Despite the potential benefits of THEDESs, concerns about their safety and toxicity remain. In this review, we summarize previous studies that have investigated the toxicity of THEDESs. These studies evaluate the toxicity of THEDESs using various methods, including cell cultures, animal models, and human trials. The results of previous findings suggest that THEDESs are generally well-tolerated and have low toxicity. However, further research is needed to fully understand the long-term effects of these systems on human health and to identify any potential adverse effects.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Drug Solubulity and Delivery Systems · Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Facultad de Ciencias de la Salud, Universidad San Jorge, Campus Universitario Villanueva de Gállego, Autov. A-23 km 299, Villanueva de Gállego, 50830 Zaragoza, Spain

Funding

Departamento de Ciencia, Universidad y Sociedad del Conocimiento, from the Gobierno de Aragón (Spain)

References (99)

Show source-provided references
1. Exploration on the drug solubility enhancement in aqueous medium with the help of endo -functionalized molecular tubes: A computational approach10.1039/D1CP01187A ↗
2. FDA (2023, May 05). Formulating Drug Products for Optimized Absorption: Elucidating Amorphous Solid Dispersions, Available online: https://www.fda.gov/drugs/regulatory-science-action/formulating-drug-products-optimized-absorption-elucidating-amorphous-solid-dispersions.
3. Insoluble drug delivery strategies: Review of recent advances and business prospects10.1016/j.apsb.2015.07.003 ↗
4. Rajpoot, K., Tekade, M., Sreeharsha, N., Sharma, M.C., and Tekade, R.K. (2020). The Future of Pharmaceutical Product Development and Research, Elsevier.
5. Drug carrier systems for solubility enhancement of BCS class II drugs: A critical review10.1615/CritRevTherDrugCarrierSyst.2013005964 ↗
6. Deep eutectic solvents as an alternate to other harmful solvents
7. Bhalani, D.V., Nutan, B., Kumar, A., and Singh Chandel, A.K. (2022). Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics. Biomedicines, 10.10.3390/biomedicines10092055 ↗
8. Drug Solubility: Importance and Enhancement Techniques
9. Techniques for Solubility Enhancement of Poorly Soluble Drugs: An Overview10.55522/jmpas.V1I1.0002 ↗
10. Technologies to Improve the Solubility, Dissolution and Bioavailability of Poorly Soluble Drugs10.15406/japlr.2018.07.00198 ↗
11. Solubility Enhancement Techniques for Poorly Water-Soluble Drugs
12. Solubility measurement and thermodynamic modeling of sertraline hydrochloride and clopidogrel bisulfate in deep eutectic solvent of choline chloride and malonic acid10.1016/j.molliq.2021.117940 ↗
13. Deep eutectic systems: An overview of fundamental aspects, current understanding and drug delivery applications10.1016/j.ijpharm.2021.121203 ↗
14. Investigation on the thermal stability of deep eutectic solvents10.3866/PKU.WHXB201712281 ↗
15. Revisiting greenness of ionic liquids and deep eutectic solvents10.1016/j.gce.2021.01.004 ↗
16. Fourmentin, S., Costa Gomes, M., and Lichtfouse, E. (2021). Deep Eutectic Solvents for Medicine, Gas Solubilization and Extraction of Natural Substances, Springer International Publishing. Environmental Chemistry for a Sustainable World.10.1007/978-3-030-53069-3 ↗
17. Interactions of natural deep eutectic solvents (NADES) with artificial and natural membranes10.1016/j.molliq.2021.115452 ↗
18. Characterization and Comparison of Lidocaine-Tetracaine and Lidocaine-Camphor Eutectic Mixtures Based on Their Crystallization and Hydrogen-Bonding Abilities10.1208/s12249-014-0242-4 ↗
19. Transdermal delivery from eutectic systems: Enhanced permeation of a model drug, ibuprofen10.1016/S0168-3659(97)00153-3 ↗
20. Liquid pharmaceuticals formulation by eutectic formation10.1016/j.fluid.2017.05.009 ↗
21. Characterizing the Solvation Characteristics of Deep Eutectic Solvents Composed of Active Pharmaceutical Ingredients as a Hydrogen Bond Donor and/or Acceptor10.1021/acssuschemeng.1c08675 ↗
22. Menthol, borneol, camphor and WS-3 eutectic mixture10.4028/www.scientific.net/AMR.506.355 ↗
23. Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles10.1016/j.ijpharm.2009.05.039 ↗
24. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies10.1016/j.ejpb.2017.02.003 ↗
25. Therapeutic deep eutectic solvent based on osthole and paeonol: Preparation, characterization, and permeation behavior10.1016/j.molliq.2021.117133 ↗
26. Lomba, L., García, C.B., Ribate, M.P., Giner, B., and Zuriaga, E. (2021). Applications of deep eutectic solvents related to health, synthesis, and extraction of natural based chemicals. Appl. Sci., 11.10.3390/app112110156 ↗
27. Therapeutic Role of Deep Eutectic Solvents Based on Menthol and Saturated Fatty Acids on Wound Healing10.1021/acsabm.9b00598 ↗
28. Boosting antibiotics performance by new formulations with deep eutectic solvents10.1016/j.ijpharm.2022.121566 ↗
29. Dissolution enhancement of active pharmaceutical ingredients by therapeutic deep eutectic systems10.1016/j.ejpb.2015.11.002 ↗
30. Selective terpene based therapeutic deep eutectic systems against colorectal cancer10.1016/j.ejpb.2022.04.008 ↗
31. Unveil the Anticancer Potential of Limomene Based Therapeutic Deep Eutectic Solvents10.1038/s41598-019-51472-7 ↗
32. Novel Deep Eutectic Solvent–Hydrogel Systems for Synergistic Transdermal Delivery of Chinese Herb Medicine and Local Treatments for Rheumatoid Arthritis10.1007/s11095-022-03239-5 ↗
33. Wang, J., Li, M., Duan, L., Lin, Y., Cui, X., Yang, Y., and Wang, C. (2022). Deep Eutectic Systems as Novel Vehicles for Assisting Drug Transdermal Delivery. Pharmaceutics, 14.10.3390/pharmaceutics14112265 ↗
34. Deep eutectic solvents for pharmaceutical formulation and drug delivery applications10.1080/10837450.2020.1735414 ↗
35. Design of controlled release systems for THEDES−Therapeutic deep eutectic solvents, using supercritical fluid technology10.1016/j.ijpharm.2015.06.038 ↗
36. Sut, S., Faggian, M., Baldan, V., Poloniato, G., Castagliuolo, I., Grabnar, I., Perissutti, B., Brun, P., Maggi, F., and Voinovich, D. (2017). Natural Deep Eutectic Solvents (NADES) to enhance berberine absorption: An in vivo pharmacokinetic study. Molecules, 22.10.3390/molecules22111921 ↗
37. Evaluation of the ROS Inhibiting Activity and Mitochondrial Targeting of Phenolic Compounds in Fibroblast Cells Model System and Enhancement of Efficiency by Natural Deep Eutectic Solvent (NADES) Formulation10.1007/s11095-017-2124-4 ↗
38. Production of Electrospun Fast-Dissolving Drug Delivery Systems with Therapeutic Eutectic Systems Encapsulated in Gelatin10.1208/s12249-016-0703-z ↗
39. Design and characterization of ascorbic acid based therapeutic deep eutectic solvent as a new ion-gel for delivery of sunitinib malate10.1016/j.jddst.2020.101512 ↗
40. Design of Functional Therapeutic Deep Eutectic Solvents Based on Choline Chloride and Ascorbic Acid10.1021/acssuschemeng.8b01687 ↗
41. Lomba, L., Ribate, M.P., Zaragoza, E., Concha, J., Garralaga, M.P., Errazquin, D., García, C.B., and Giner, B. (2021). Deep eutectic solvents: Are they safe?. Appl. Sci., 11.10.3390/app112110061 ↗
42. Hayyan, M., Looi, C.Y., Hayyan, A., Wong, W.F., and Hashim, M.A. (2015). In Vitro and in Vivo toxicity profiling of ammonium-based deep eutectic solvents. PLoS ONE, 10.10.1371/journal.pone.0117934 ↗
43. Evaluation of toxicity and biodegradability of choline chloride based deep eutectic solvents10.1016/j.ecoenv.2014.09.034 ↗
44. Cytotoxicity profiling of deep eutectic solvents to human skin cells10.1038/s41598-019-39910-y ↗
45. Natural deep eutectic solvents-Solvents for the 21st century. ACS Sustain
46. Natural deep eutectic solvents: Cytotoxic profile10.1186/s40064-016-2575-9 ↗
47. Assessment of cytotoxicity and toxicity for phosphonium-based deep eutectic solvents10.1016/j.chemosphere.2013.05.013 ↗
48. Biocompatible Deep Eutectic Solvents Based on Choline Chloride: Characterization and Application to the Extraction of Rutin from Sophora japonica10.1021/acssuschemeng.5b00619 ↗
49. Deep eutectic solvent for an expeditious sono-synthesis of novel series of bis-quinazolin-4-one derivatives as potential anti-cancer agents10.1098/rsos.182046 ↗
50. Unraveling the cytotoxicity and metabolic pathways of binary natural deep eutectic solvent systems10.1038/srep41257 ↗
51. Exploring cytotoxicity of some choline-based deep eutectic solvents and their effect on the solubility of lamotrigine in aqueous media10.1016/j.molliq.2019.03.079 ↗
52. Hydrophobic deep eutectic solvents as water-immiscible extractants10.1039/C5GC01451D ↗
53. Cytotoxicity of some choline-based deep eutectic solvents and their effect on solubility of coumarin drug10.1016/j.ejps.2021.106022 ↗
54. Ibuprofen solubility and cytotoxic study of deep eutectic solvents formed by xylitol, choline chloride and water10.1016/j.jddst.2023.104327 ↗
55. Pedro, S.N., Mendes, M.S.M., Neves, B.M., Almeida, I.F., Costa, P., Correia-Sá, I., Vilela, C., Freire, M.G., Silvestre, A.J.D., and Freire, C.S.R. (2022). Deep Eutectic Solvent Formulations and Alginate-Based Hydrogels as a New Partnership for the Transdermal Administration of Anti-Inflammatory Drugs. Pharmaceutics, 14.10.3390/pharmaceutics14040827 ↗
56. Betaine-urea deep eutectic solvent improves imipenem antibiotic activity10.1016/j.molliq.2022.118551 ↗
57. Insight into the physicochemical properties and bioactivities of therapeutic deep eutectic solvents based on matrine and fatty acids10.1016/j.molliq.2022.119560 ↗
58. Antiamoebic properties of salicylic acid-based deep eutectic solvents for the development of contact lens disinfecting solutions against Acanthamoeba10.1016/j.molbiopara.2022.111493 ↗
59. Oliveira, F., Santos, F., and Duarte, A.R.C. (2021). Therapeutic deep eutectic systems towards the treatment of tuberculosis and colorectal cancer: Opportunities and challenges. Molecules, 26.10.3390/molecules26227022 ↗
60. Sarraguça, M.C., Ribeiro, P.R.S., Nunes, C., and Seabra, C.L. (2022). Solids Turn into Liquids—Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility. Pharmaceuticals, 15.10.3390/ph15030279 ↗
61. Santos, F., Leitão, M.I.P.S., and Duarte, A.R.C. (2019). Properties of therapeutic deep eutectic solvents of L-arginine and ethambutol for tuberculosis treatment. Molecules, 24.10.3390/molecules24010055 ↗
62. Design and processing of drug delivery formulations of therapeutic deep eutectic systems for tuberculosis10.1016/j.supflu.2020.104826 ↗
63. De Oliveira, F.S.N., and Duarte, A.R.C. (2021). A Look on Target-Specificity of Eutectic Systems Based on Natural Bioactive Compounds, Elsevier Ltd.. [1st ed.].10.1016/bs.abr.2020.09.008 ↗
64. Extracts of medicinal plants with natural deep eutectic solvents: Enhanced antimicrobial activity and low genotoxicity10.1186/s13065-020-00726-x ↗
65. Mattioli, R., Di Risola, D., Federico, R., Ciogli, A., Gasparrini, F., Villani, C., Fontana, M., Maggiore, A., D’erme, M., and Mosca, L. (2022). Effect of Natural Deep Eutectic Solvents on trans-Resveratrol Photo-Chemical Induced Isomerization and 2,4,6-Trihydroxyphenanthrene Electro-Cyclic Formation. Molecules, 27.10.3390/molecules27072348 ↗
66. Resveratrol-Linoleate protects from exacerbated endothelial permeability via a drastic inhibition of the MMP-9 activity10.1042/BSR20171712 ↗
67. Protective effects of glycerol and xylitol in keratinocytes exposed to hyperosmotic stress10.2147/CCID.S197946 ↗
68. Lee, K.C., Wu, K.L., Chang, S.F., Chang, H.I., Chen, C.N., and Chen, Y.Y. (2022). Fermented Ginger Extract in Natural Deep Eutectic Solvent Enhances Cytotoxicity by Inhibiting NF-κB Mediated CXC Chemokine Receptor 4 Expression in Oxaliplatin-Resistant Human Colorectal Cancer Cells. Antioxidants, 11.10.3390/antiox11102057 ↗
69. Cytotoxicity, genotoxicity, oxidative stress, and apoptosis in HepG2 cells induced by the imidazole ionic liquid 1-dodecyl-3-methylimidazolium chloride10.1002/tox.22901 ↗
70. Ecotoxicity and biodegradability of pure and aqueous mixtures of deep eutectic solvents: Glyceline, ethaline, and reline10.1007/s11356-020-11144-w ↗
71. Are natural deep eutectic solvents always a sustainable option? A bioassay-based study10.1007/s11356-022-23362-5 ↗
72. Assessing the toxicity and biodegradability of deep eutectic solvents10.1016/j.chemosphere.2015.02.061 ↗
73. Toxicity of Natural Deep Eutectic Solvent Betaine: Glycerol in Rats10.1021/acs.jafc.8b01746 ↗
74. Oral ionic liquid for the treatment of diet-induced obesity10.1073/pnas.1914426116 ↗
75. Intra-Herb Interactions: Primary Metabolites in Coptidis Rhizoma Extract Improved the Pharmacokinetics of Oral Berberine Hydrochloride in Mice
76. Deep Eutectic Solvent-Mediated FA-g-β-Alanine-co-PCL Drug Carrier for Sustainable and Site-Specific Drug Delivery10.1021/acsabm.8b00554 ↗
77. Greener extraction process and enhanced in vivo bioavailability of bioactive components from Carthamus tinctorius L. by natural deep eutectic solvents10.1016/j.foodchem.2021.129090 ↗
78. Oral Bioavailability-Enhancing and Anti-obesity Effects of Hydroxysafflor Yellow A in Natural Deep Eutectic Solvent10.1021/acsomega.2c00457 ↗
79. Natural deep eutectic solvent (NADES): A strategy to improve the bioavailability of blueberry phenolic compounds in a ready-to-use extract10.1016/j.foodchem.2021.130370 ↗
80. Semenov, A.L., Tyndyk, M.L., Von, J.D., Ermakova, E.D., Dorofeeva, A.A., Tumanyan, I.A., Radetskaya, E.A., Yurova, M.N., Zherebker, A., and Gorbunov, A.Y. (2023). Effects of Isoflavone-Rich NADES Extract of Pueraria lobata Roots and Astaxanthin-Rich Phaffia rhodozyma Extract on Prostate Carcinogenesis in Rats. Plants, 12.10.3390/plants12030564 ↗
81. A Deep Eutectic Solvent-Based Approach to Intravenous Formulation10.1002/adhm.202100585 ↗
82. A deep eutectic-based, self-emulsifying subcutaneous depot system for apomorphine therapy in Parkinson’s disease10.1073/pnas.2110450119 ↗
83. Transdermal Protein Delivery Using Choline and Geranate (CAGE) Deep Eutectic Solvent10.1002/adhm.201601411 ↗
84. Transdermal insulin delivery using choline-based ionic liquids (CAGE)10.1016/j.jconrel.2018.07.029 ↗
85. Deep Eutectic Solvents for Subcutaneous Delivery of Protein Therapeutics10.1002/advs.202205389 ↗
86. Khamoushian, S., Madrakian, T., Afkhami, A., Ghoorchian, A., Ghavami, S., Tari, K., and Samarghandi, M.R. (2023). Transdermal Delivery of Insulin Using Combination of Iontophoresis and Deep Eutectic Solvents as Chemical Penetration Enhancers: In Vitro and in Vivo Evaluations. J. Pharm. Sci., in press.10.1016/j.xphs.2023.03.005 ↗
87. A Novel Eutectic-Based Transdermal Delivery System for Risperidone
88. Deep eutectic solvents—Hydrogels for the topical management of rheumatoid arthritis10.1016/j.jconrel.2023.01.050 ↗
89. Novel amorphous solid dispersion based on natural deep eutectic solvent for enhancing delivery of anti-tumor RA-XII by oral administration in rats10.1016/j.ejps.2021.105931 ↗
90. Formation of Diacerein − fumaric acid eutectic as a multi-component system for the functionality enhancement10.1016/j.jddst.2020.101562 ↗
91. Influence of eutectic mixture as a multi-component system in the improvement of physicomechanical and pharmacokinetic properties of diacerein10.1016/j.apt.2020.01.021 ↗
92. The effect of deep eutectic solvent on the pharmacokinetics of salvianolic acid B in rats and its acute toxicity test10.1016/j.jchromb.2017.08.016 ↗
93. Ionic liquids for oral insulin delivery10.1073/pnas.1722338115 ↗
94. Ionic liquid-mediated delivery of insulin to buccal mucosa10.1016/j.jconrel.2020.07.037 ↗
95. Improving the hypoglycemic effect of insulin via the nasal administration of deep eutectic solvents10.1016/j.ijpharm.2019.118584 ↗
96. Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models10.1016/j.addr.2007.07.004 ↗
97. Clinical translation of choline and geranic acid deep eutectic solvent10.1002/btm2.10191 ↗
98. Choline and Geranate Deep Eutectic Solvent as a Broad-Spectrum Antiseptic Agent for Preventive and Therapeutic Applications10.1002/adhm.201600086 ↗
99. (2023, March 24). API|cgb-400. Available online: https://www.cdek.liu.edu/api/119951/#trials.